GuidanceSKIN significantly lowered its FY24 guidance, with EBITDA falling from over $40 million to a range of -$10 million to $0.
Sales PerformanceSKIN reported a significant drop in 2Q sales, down 22.9% to $90.6 million, missing both internal and market estimates.
Segment PerformanceThe Delivery Systems segment remains under pressure, experiencing a 46% decline due to execution issues and a tougher financing environment.